What is Levomilnacipran?

Category: Prescription Drugs

Most popular types: Fetzima

false

Levomilnacipran is a drug that acts as a serotonin-norepinephrine reuptake inhibitor (SNRI). It is used for the treatment of depression.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Major depressive disorder 52 31
Depressed mood 20 11
Fibromyalgia 10 4
Bipolar disorder 4 4
Anxious mood 2 0
Bipolar I disorder 2 3

Show all 15 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 10
Moderate 6
Mild 7
None 14

Commonly reported side effects and conditions associated with Levomilnacipran

Side effect Patients Percentage
Excessive anger 3
Excessive sweating 3
Tachycardia (fast heart rate) 3
Anxious mood 2
Dizziness 2
Easily angry 2

Show all 42 reported side effects

Why patients stopped taking Levomilnacipran

Multiple reasons could be selected

Reason Patients Percentage
Side effects too severe 18
Did not seem to work 14
Doctor's advice 7
Expense 3
Other 3
Course of treatment ended 2
Change in health plan coverage 1
See all 31 patients who've stopped taking Levomilnacipran

Duration

Stopped taking Levomilnacipran

Duration Patients Percentage
Less than 1 month 10
1 - 6 months 9
6 months - 1 year 5
1 - 2 years 6
Adherence
Adherence Evaluations Percentage
Always 34
Usually 2
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 2
A little hard to take 5
Not at all hard to take 30
Cost per month
Cost per month Evaluations Percentage
$200+ 2
$100-199 1
$50-99 6
$25-49 5
< $25 10
Not specified 13

What people switch to and from

Patients started taking Levomilnacipran after stopping:

Treatment Patients Percentage
Duloxetine (Cymbalta) 10
Venlafaxine (Effexor XR) 6
Sertraline (Zoloft) 5
Bupropion (Wellbutrin) 4
Fluoxetine (Prozac) 4

Show all 19 treatments patients report switching from

Patients stopped taking Levomilnacipran and switched to:

Treatment Patients Percentage
Duloxetine (Cymbalta) 5
Sertraline (Zoloft) 3
Escitalopram (Lexapro) 2
Venlafaxine (Effexor XR) 2
Vortioxetine (Trintellix) 2

Show all 17 treatments patients report switching to

Last updated:
There are no evaluations for Levomilnacipran.